Operating Expenses

R&D

HP R&D decreased by 1.5% to $392.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 1.3%, from $397.00M to $392.00M. Over 4 years (FY 2021 to FY 2025), R&D shows a downward trend with a -3.5% CAGR.

Analysis

StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026

How to read this metric

Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.

Detailed definition

Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...

Peer comparison

Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.

Metric ID: research_and_development

Historical Data

20 periods
 Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$514.00M$477.00M$386.00M$478.00M$425.00M$368.00M$382.00M$403.00M$410.00M$354.00M$411.00M$399.00M$436.00M$413.00M$392.00M$397.00M$401.00M$406.00M$398.00M$392.00M
QoQ Change-7.2%-19.1%+23.8%-11.1%-13.4%+3.8%+5.5%+1.7%-13.7%+16.1%-2.9%+9.3%-5.3%-5.1%+1.3%+1.0%+1.2%-2.0%-1.5%
YoY Change-17.3%-22.9%-1.0%-15.7%-3.5%-3.8%+7.6%-1.0%+6.3%+16.7%-4.6%-0.5%-8.0%-1.7%+1.5%-1.3%
Range$354.00M$514.00M
CAGR-5.5%
Avg YoY Growth-3.1%
Median YoY Growth-1.5%
Current Streak2 quarters decline

Frequently Asked Questions

What is HP's r&d?
HP (HPQ) reported r&d of $392.00M in Q4 2025.
How has HP's r&d changed year-over-year?
HP's r&d decreased by 1.3% year-over-year, from $397.00M to $392.00M.
What is the long-term trend for HP's r&d?
Over 4 years (2021 to 2025), HP's r&d has grown at a -3.5% compound annual growth rate (CAGR), from $1.85B to $1.60B.
What does r&d mean?
The money spent on creating new products or improving existing ones to drive future growth.